These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

44 related items for PubMed ID: 6324548

  • 1. [Semisynthetic penicillins. XXVI. Therapeutic effect of 6-beta-amidinopenicillanic acid derivatives in Balb/c mice experimentally infected with gram-negative bacteria].
    Zaremba M, Kacprzak-Wiatr A, Grala-Kałuzna A, Zukowska K, Czeczuga E, Musiatowicz B, Borowski J, Buśko-Oszczapowicz B, Cieślak J.
    Acta Pol Pharm; 1983; 40(4):507-16. PubMed ID: 6324548
    [No Abstract] [Full Text] [Related]

  • 2. [Semisynthetic penicillins. XXV. Therapeutic effect of hetacillin acetylmethyl ester hydrochloride (CEAH) in Balb/c mice experimentally infected with gram-negative bacteria].
    Zaremba M, Kacprzak-Wiatr A, Grala-Kałuzna A, Karpińska B, Borowski J, Buśko-Oszczapowicz I, Cieślak J.
    Acta Pol Pharm; 1983; 40(4):497-506. PubMed ID: 6673511
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of a derivative of 6-beta-amidino penicillanic acid (preparation HX) in urinary tract infections].
    Musierowicz A, Borowski J, Zaremba M, Prokopowicz J, Darewicz J, Gruszecki W, Pachman A.
    Pol Tyg Lek; 1980 Jul 07; 35(27):1017-9. PubMed ID: 6252549
    [No Abstract] [Full Text] [Related]

  • 4. [New semisynthetic penicillins obtained by coupling 6-aminopenicillanic acid with cinnamic acid derivatives].
    Dragomir B, Ghimicescu C, Sunel V, Zvorişteanu V, Groll M.
    Rev Med Chir Soc Med Nat Iasi; 1977 Jul 07; 81(3):489-94. PubMed ID: 202008
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
    Gesser RM, McCarroll K, Teppler H, Woods GL.
    J Antimicrob Chemother; 2003 May 07; 51(5):1253-60. PubMed ID: 12697633
    [Abstract] [Full Text] [Related]

  • 6. In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria.
    Obi CL, Makandiramba B, Robertson V, Tswana SA, Moyo SR, Nziramasanga P.
    East Afr Med J; 1998 Mar 07; 75(3):162-5. PubMed ID: 9640815
    [Abstract] [Full Text] [Related]

  • 7. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS, Frei CR.
    J Antimicrob Chemother; 2005 Nov 07; 56(5):893-8. PubMed ID: 16162664
    [Abstract] [Full Text] [Related]

  • 8. [Semisynthetic penicillins. X. Synthesis of 6-formamidinopenicillanic acid derivatives of cyclic secondary amines].
    Buśko-Oszczapowicz I, Cieślak J.
    Acta Pol Pharm; 1973 Nov 07; 30(1):43-8. PubMed ID: 4348677
    [No Abstract] [Full Text] [Related]

  • 9. [Semisynthetic penicillins. XV. Synthesis and properties of 6-(N,N-1', 6'-hexyleneformamidino)-penicillanic acid pivaloyloxymethyl ester hydrochloride].
    Buśko-Oszczapowicz I, Kazimierczak J, Prussak T, Marchlewska Z, Kaluza A, Cieniecka A, Cieślak J.
    Acta Pol Pharm; 1976 Nov 07; 33(2):191-7. PubMed ID: 180753
    [No Abstract] [Full Text] [Related]

  • 10. [Synthetic penicillins. Properties of new amidinopenicillins and their acetylmethyl esters].
    Cieślak J, Buśko-Oszczapowicz I, Rogowska W, Stepniak M, Sadowska J, Kotula W, Całka A, Prussak-Wieckowska T, Marchlewska Z.
    Acta Pol Pharm; 1981 Nov 07; 38(4):499-505. PubMed ID: 6277150
    [No Abstract] [Full Text] [Related]

  • 11. [Toxicology of 6-aminopenicillanic acid, chief product of the manufacture of semisynthetic penicillins].
    Zel'tser IZ, Sergeeva EI, Balabanova EL, Lapchinskaia AV, Baru RV.
    Gig Tr Prof Zabol; 1983 May 07; (5):59-60. PubMed ID: 6307835
    [No Abstract] [Full Text] [Related]

  • 12. Community-acquired bacteraemia and antibiotic resistance. Trends during a 17-year period in a Danish county.
    Pedersen G, Schønheyder HC, Kristensen B, Sørensen HT.
    Dan Med Bull; 2000 Sep 07; 47(4):296-300. PubMed ID: 11064832
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002.
    Frei CR, Burgess DS.
    Clin Ther; 2008 Dec 07; 30(12):2335-41. PubMed ID: 19167592
    [Abstract] [Full Text] [Related]

  • 14. Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
    Kuck NA, Petersen PJ, Weiss WJ, Jacobus NV, Testa RT, Tally FP.
    J Chemother; 1989 Jul 07; 1(4 Suppl):105-6. PubMed ID: 16312325
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA, Kumar AK.
    Saudi Med J; 2004 May 07; 25(5):570-4. PubMed ID: 15138522
    [Abstract] [Full Text] [Related]

  • 16. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K, Reshedko G, Orasan R, Sanchez M, Teras J, Babinchak T, Dukart G, Cooper A, Dartois N, Gandjini H, Orrico R, Ellis-Grosse E, 309 Study Group.
    J Antimicrob Chemother; 2008 Sep 07; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Laboratory studies with carbenicillin.
    English.
    Antimicrob Agents Chemother (Bethesda); 1968 Sep 07; 8():482-8. PubMed ID: 5735396
    [No Abstract] [Full Text] [Related]

  • 19. TNF-alpha hyper-responses to Gram-negative and Gram-positive bacteria in Propionibacterium acnes primed or Salmonella typhimurium infected mice.
    Merlin T, Gumenscheimer M, Galanos C, Freudenberg MA.
    J Endotoxin Res; 2001 Sep 07; 7(2):157-63. PubMed ID: 11521096
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb 07; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.